To determine the human IgG‐based antibody concentrations in serum and hepatic tissue samples, 96‐well ELISA plates were precoated with an anti‐human IgG antibody (Fab specific; Sigma‒Aldrich, USA) and appropriately blocked. Serum or liver lysate samples were diluted and added to the reaction wells. Antibodies were detected with an HRP‐conjugated anti‐human kappa light chain secondary antibody (Invitrogen, USA), and a chromogenic substrate and stop solution was subsequently used. The antibody concentrations were quantified by using
human IgG from serum (Sigma‒Aldrich, USA) with known concentrations as standards.
For the detection of serum ant‐HBs levels, recombinant HBsAg protein (2 µg mL
−1) was coated onto ELISA 96‐well plates. Serum samples were diluted 50‐fold and added to pre‐coated HBsAg. The presence of mouse anti‐HBs was detected using
HRP‐conjugated goat anti‐mouse IgG (H+L) secondary antibody (ab6789, Abcam, UK). The following steps were performed according to the manufacturer's protocols.
Jiang Y., Chen X., Ye X., Wen C., Xu T., Yu C., Ning W., Wang G., Xiang X., Liu X., Wang Y., Chen Y., Liu X., Shi C., Liu C., Yuan Q., Chen Y., Zhang T., Luo W, & Xia N. (2024). A Dual‐domain Engineered Antibody for Efficient HBV Suppression and Immune Responses Restoration. Advanced Science, 11(15), 2305316.